

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T cell migration (GO:0072678) | 6.72028070 |
| 2 | regulation of B cell receptor signaling pathway (GO:0050855) | 6.12035427 |
| 3 | cellular response to zinc ion (GO:0071294) | 5.78549093 |
| 4 | activated T cell proliferation (GO:0050798) | 5.65635922 |
| 5 | protein K63-linked deubiquitination (GO:0070536) | 5.60540827 |
| 6 | cellular response to ATP (GO:0071318) | 5.59352451 |
| 7 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 5.52429518 |
| 8 | negative regulation of execution phase of apoptosis (GO:1900118) | 5.39148151 |
| 9 | positive T cell selection (GO:0043368) | 5.18421036 |
| 10 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.13577638 |
| 11 | positive thymic T cell selection (GO:0045059) | 4.99053461 |
| 12 | negative T cell selection (GO:0043383) | 4.88784462 |
| 13 | thymic T cell selection (GO:0045061) | 4.81643031 |
| 14 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.77233695 |
| 15 | negative regulation of cell killing (GO:0031342) | 4.77233695 |
| 16 | GDP-mannose metabolic process (GO:0019673) | 4.65385440 |
| 17 | glomerular visceral epithelial cell development (GO:0072015) | 4.50462553 |
| 18 | T cell selection (GO:0045058) | 4.41266830 |
| 19 | cellular response to interleukin-15 (GO:0071350) | 4.40859742 |
| 20 | positive regulation of keratinocyte differentiation (GO:0045618) | 4.39672685 |
| 21 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.39114428 |
| 22 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.37012145 |
| 23 | protein K11-linked deubiquitination (GO:0035871) | 4.28841790 |
| 24 | programmed necrotic cell death (GO:0097300) | 4.25232761 |
| 25 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.21832484 |
| 26 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.12122767 |
| 27 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.11704075 |
| 28 | response to interleukin-15 (GO:0070672) | 4.11127525 |
| 29 | protein K48-linked deubiquitination (GO:0071108) | 4.10825298 |
| 30 | negative regulation of interleukin-12 production (GO:0032695) | 3.97680775 |
| 31 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.95545793 |
| 32 | glomerular epithelial cell development (GO:0072310) | 3.95237021 |
| 33 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.94514860 |
| 34 | necrotic cell death (GO:0070265) | 3.91462757 |
| 35 | necroptotic process (GO:0070266) | 3.91428090 |
| 36 | negative thymic T cell selection (GO:0045060) | 3.89340080 |
| 37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.80732697 |
| 38 | regulation of B cell differentiation (GO:0045577) | 3.77065646 |
| 39 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.76853419 |
| 40 | regulation of defense response to virus by host (GO:0050691) | 3.75263453 |
| 41 | regulation of isotype switching to IgG isotypes (GO:0048302) | 3.75085679 |
| 42 | maturation of SSU-rRNA (GO:0030490) | 3.74292158 |
| 43 | positive regulation of endothelial cell differentiation (GO:0045603) | 3.73336294 |
| 44 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.72940886 |
| 45 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 3.65358702 |
| 46 | B cell receptor signaling pathway (GO:0050853) | 3.62843610 |
| 47 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.62157442 |
| 48 | cytokine biosynthetic process (GO:0042089) | 3.58279607 |
| 49 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.56217749 |
| 50 | negative regulation of T cell mediated immunity (GO:0002710) | 3.56165690 |
| 51 | regulation of regulatory T cell differentiation (GO:0045589) | 3.55045934 |
| 52 | lymphocyte migration (GO:0072676) | 3.53987843 |
| 53 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.52911876 |
| 54 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.51946513 |
| 55 | sequestering of metal ion (GO:0051238) | 3.49760500 |
| 56 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.47626091 |
| 57 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.46105849 |
| 58 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.46105849 |
| 59 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.44525952 |
| 60 | lymphocyte chemotaxis (GO:0048247) | 3.41924811 |
| 61 | T cell mediated immunity (GO:0002456) | 3.41419575 |
| 62 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.40318731 |
| 63 | interferon-gamma production (GO:0032609) | 3.38631028 |
| 64 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.37653304 |
| 65 | negative regulation of T cell apoptotic process (GO:0070233) | 3.37611286 |
| 66 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.34355156 |
| 67 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.34212240 |
| 68 | N-acetylneuraminate metabolic process (GO:0006054) | 3.33728384 |
| 69 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.32963019 |
| 70 | positive regulation of B cell differentiation (GO:0045579) | 3.31148490 |
| 71 | base-excision repair, AP site formation (GO:0006285) | 3.31018566 |
| 72 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.28498867 |
| 73 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.24952623 |
| 74 | regulation of T cell tolerance induction (GO:0002664) | 3.22570619 |
| 75 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.22344516 |
| 76 | cytolysis (GO:0019835) | 3.21567557 |
| 77 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.21517658 |
| 78 | positive regulation of cell killing (GO:0031343) | 3.20642348 |
| 79 | T cell receptor signaling pathway (GO:0050852) | 3.19996653 |
| 80 | lipopolysaccharide metabolic process (GO:0008653) | 3.19414085 |
| 81 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.18373186 |
| 82 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.16822908 |
| 83 | leukocyte aggregation (GO:0070486) | 3.16577234 |
| 84 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.16397365 |
| 85 | T-helper cell differentiation (GO:0042093) | 3.16200207 |
| 86 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.16200207 |
| 87 | chemokine-mediated signaling pathway (GO:0070098) | 3.15130581 |
| 88 | mannosylation (GO:0097502) | 3.13998125 |
| 89 | negative regulation of macroautophagy (GO:0016242) | 3.11517621 |
| 90 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.09692151 |
| 91 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.08282852 |
| 92 | regulation of guanylate cyclase activity (GO:0031282) | 3.06405170 |
| 93 | response to type I interferon (GO:0034340) | 3.05259012 |
| 94 | type I interferon signaling pathway (GO:0060337) | 3.04292146 |
| 95 | cellular response to type I interferon (GO:0071357) | 3.04292146 |
| 96 | regulation of cell killing (GO:0031341) | 3.03541784 |
| 97 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.03465225 |
| 98 | negative regulation of type I interferon production (GO:0032480) | 3.02144228 |
| 99 | regulation of chronic inflammatory response (GO:0002676) | 3.01776347 |
| 100 | macrophage chemotaxis (GO:0048246) | 2.98273843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 5.52440410 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.13270530 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.47292907 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.26054725 |
| 5 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 4.17884357 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.13373173 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.35348016 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.21427403 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.97103990 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.75397942 |
| 11 | MYB_26560356_Chip-Seq_TH2_Human | 2.71034239 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.61897330 |
| 13 | MAF_26560356_Chip-Seq_TH1_Human | 2.60713694 |
| 14 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.52496118 |
| 15 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.50399554 |
| 16 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.47806439 |
| 17 | UTX_26944678_Chip-Seq_JUKART_Human | 2.42337328 |
| 18 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.31692072 |
| 19 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.27319022 |
| 20 | MYB_26560356_Chip-Seq_TH1_Human | 2.22909502 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.15191780 |
| 22 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.13109955 |
| 23 | MAF_26560356_Chip-Seq_TH2_Human | 2.07390878 |
| 24 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.05355226 |
| 25 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.03201554 |
| 26 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.03201554 |
| 27 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.03201554 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.94466291 |
| 29 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.93456111 |
| 30 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.88443051 |
| 31 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.84015198 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75519189 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.75331735 |
| 34 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.72964222 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57745454 |
| 36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52568874 |
| 37 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.47912427 |
| 38 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.41897531 |
| 39 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.41450963 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.30285841 |
| 41 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.28629674 |
| 42 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.27707292 |
| 43 | GATA3_26560356_Chip-Seq_TH2_Human | 1.26536774 |
| 44 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.26368828 |
| 45 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.21608612 |
| 46 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.21413911 |
| 47 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.20407921 |
| 48 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20283495 |
| 49 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15786889 |
| 50 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.15020575 |
| 51 | SA1_27219007_Chip-Seq_Bcells_Human | 1.13759732 |
| 52 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.13417257 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11718560 |
| 54 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.11611006 |
| 55 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.10477085 |
| 56 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10408885 |
| 57 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.09629864 |
| 58 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.08798290 |
| 59 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08779244 |
| 60 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08192912 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.07997418 |
| 62 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.06363234 |
| 63 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.05664731 |
| 64 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04060589 |
| 65 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98995738 |
| 66 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.97466527 |
| 67 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.97177467 |
| 68 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.96413706 |
| 69 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.94300455 |
| 70 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.92723729 |
| 71 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.92552498 |
| 72 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91929289 |
| 73 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.91550883 |
| 74 | P300_27268052_Chip-Seq_Bcells_Human | 0.90359248 |
| 75 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.89830494 |
| 76 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.89630221 |
| 77 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87347630 |
| 78 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.87253952 |
| 79 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.87006103 |
| 80 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.86972643 |
| 81 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.85745388 |
| 82 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.84517794 |
| 83 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.84348001 |
| 84 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.82800822 |
| 85 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.82720694 |
| 86 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81615380 |
| 87 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.80743999 |
| 88 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.80371440 |
| 89 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.80192233 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80175464 |
| 91 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.78542578 |
| 92 | MYC_22102868_ChIP-Seq_BL_Human | 0.77569278 |
| 93 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.77044804 |
| 94 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.76843739 |
| 95 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.76337067 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76334703 |
| 97 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.74867472 |
| 98 | SPI1_23127762_ChIP-Seq_K562_Human | 0.74771199 |
| 99 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74055399 |
| 100 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.73871751 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 5.86255486 |
| 2 | MP0003045_fibrosis | 4.37397603 |
| 3 | MP0003763_abnormal_thymus_physiology | 3.75561488 |
| 4 | MP0003300_gastrointestinal_ulcer | 3.29387561 |
| 5 | MP0001790_abnormal_immune_system | 3.25226838 |
| 6 | MP0005387_immune_system_phenotype | 3.25226838 |
| 7 | MP0009785_altered_susceptibility_to | 3.20965517 |
| 8 | MP0001800_abnormal_humoral_immune | 2.82306234 |
| 9 | MP0002166_altered_tumor_susceptibility | 2.80944605 |
| 10 | MP0006082_CNS_inflammation | 2.72731759 |
| 11 | MP0003436_decreased_susceptibility_to | 2.57872338 |
| 12 | MP0001873_stomach_inflammation | 2.54010382 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.45430024 |
| 14 | MP0005025_abnormal_response_to | 2.40772943 |
| 15 | MP0002723_abnormal_immune_serum | 2.39455885 |
| 16 | MP0005000_abnormal_immune_tolerance | 2.37529334 |
| 17 | MP0009333_abnormal_splenocyte_physiolog | 2.35983706 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.35572914 |
| 19 | MP0002405_respiratory_system_inflammati | 2.34541969 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.31729003 |
| 21 | MP0001819_abnormal_immune_cell | 2.24555299 |
| 22 | MP0002653_abnormal_ependyma_morphology | 2.11846786 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.11083526 |
| 24 | MP0010155_abnormal_intestine_physiology | 2.06584527 |
| 25 | MP0002419_abnormal_innate_immunity | 1.96141146 |
| 26 | MP0002009_preneoplasia | 1.96054510 |
| 27 | MP0003866_abnormal_defecation | 1.95229560 |
| 28 | MP0002006_tumorigenesis | 1.93541449 |
| 29 | MP0002277_abnormal_respiratory_mucosa | 1.82782051 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.81025485 |
| 31 | MP0001851_eye_inflammation | 1.80505539 |
| 32 | MP0000685_abnormal_immune_system | 1.80456011 |
| 33 | MP0002398_abnormal_bone_marrow | 1.70779900 |
| 34 | MP0005408_hypopigmentation | 1.69444990 |
| 35 | MP0000716_abnormal_immune_system | 1.68853076 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.67827111 |
| 37 | MP0004142_abnormal_muscle_tone | 1.64167939 |
| 38 | MP0003448_altered_tumor_morphology | 1.60231998 |
| 39 | MP0005083_abnormal_biliary_tract | 1.59973566 |
| 40 | MP0000703_abnormal_thymus_morphology | 1.59607938 |
| 41 | MP0003806_abnormal_nucleotide_metabolis | 1.50998739 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.43860346 |
| 43 | MP0003646_muscle_fatigue | 1.42913537 |
| 44 | MP0003693_abnormal_embryo_hatching | 1.41449337 |
| 45 | MP0005310_abnormal_salivary_gland | 1.39817818 |
| 46 | MP0003890_abnormal_embryonic-extraembry | 1.38572392 |
| 47 | MP0002168_other_aberrant_phenotype | 1.36441050 |
| 48 | MP0002429_abnormal_blood_cell | 1.36055589 |
| 49 | MP0008469_abnormal_protein_level | 1.32868960 |
| 50 | MP0002722_abnormal_immune_system | 1.32797773 |
| 51 | MP0003724_increased_susceptibility_to | 1.25612561 |
| 52 | MP0002163_abnormal_gland_morphology | 1.21680785 |
| 53 | MP0000470_abnormal_stomach_morphology | 1.21345805 |
| 54 | MP0004947_skin_inflammation | 1.16323447 |
| 55 | MP0004381_abnormal_hair_follicle | 1.15187607 |
| 56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.14336572 |
| 57 | MP0000678_abnormal_parathyroid_gland | 1.12918881 |
| 58 | MP0005166_decreased_susceptibility_to | 1.09979075 |
| 59 | MP0008569_lethality_at_weaning | 1.06407589 |
| 60 | MP0001348_abnormal_lacrimal_gland | 1.05000891 |
| 61 | MP0003252_abnormal_bile_duct | 1.04161144 |
| 62 | MP0005451_abnormal_body_composition | 1.03180605 |
| 63 | MP0008007_abnormal_cellular_replicative | 1.02231659 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 0.94356733 |
| 65 | MP0003786_premature_aging | 0.94034758 |
| 66 | MP0001533_abnormal_skeleton_physiology | 0.92733539 |
| 67 | MP0008872_abnormal_physiological_respon | 0.91604430 |
| 68 | MP0000569_abnormal_digit_pigmentation | 0.90662642 |
| 69 | MP0003638_abnormal_response/metabolism_ | 0.86866850 |
| 70 | MP0003950_abnormal_plasma_membrane | 0.86490209 |
| 71 | MP0008004_abnormal_stomach_pH | 0.86115508 |
| 72 | MP0002933_joint_inflammation | 0.85251466 |
| 73 | MP0002928_abnormal_bile_duct | 0.84044414 |
| 74 | MP0001501_abnormal_sleep_pattern | 0.83402369 |
| 75 | MP0005645_abnormal_hypothalamus_physiol | 0.78692300 |
| 76 | MP0005076_abnormal_cell_differentiation | 0.77221133 |
| 77 | MP0001919_abnormal_reproductive_system | 0.73080609 |
| 78 | MP0005379_endocrine/exocrine_gland_phen | 0.71301101 |
| 79 | MP0003191_abnormal_cellular_cholesterol | 0.71131230 |
| 80 | MP0005464_abnormal_platelet_physiology | 0.68811239 |
| 81 | MP0001958_emphysema | 0.68681300 |
| 82 | MP0009764_decreased_sensitivity_to | 0.67966854 |
| 83 | MP0001853_heart_inflammation | 0.66523406 |
| 84 | MP0005084_abnormal_gallbladder_morpholo | 0.65557217 |
| 85 | MP0005075_abnormal_melanosome_morpholog | 0.65124106 |
| 86 | MP0009643_abnormal_urine_homeostasis | 0.63837181 |
| 87 | MP0004043_abnormal_pH_regulation | 0.63772064 |
| 88 | MP0005167_abnormal_blood-brain_barrier | 0.61397484 |
| 89 | MP0001765_abnormal_ion_homeostasis | 0.61288959 |
| 90 | MP0009763_increased_sensitivity_to | 0.59271616 |
| 91 | MP0008873_increased_physiological_sensi | 0.57728388 |
| 92 | MP0008058_abnormal_DNA_repair | 0.56407380 |
| 93 | MP0000920_abnormal_myelination | 0.56250491 |
| 94 | MP0003075_altered_response_to | 0.55476750 |
| 95 | MP0002136_abnormal_kidney_physiology | 0.54478094 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.54208915 |
| 97 | MP0003303_peritoneal_inflammation | 0.51245137 |
| 98 | MP0003195_calcinosis | 0.48406788 |
| 99 | MP0002693_abnormal_pancreas_physiology | 0.48303183 |
| 100 | MP0002736_abnormal_nociception_after | 0.48223886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of DNA repair (HP:0003254) | 6.53048170 |
| 2 | Type I transferrin isoform profile (HP:0003642) | 5.75945890 |
| 3 | Hypoproteinemia (HP:0003075) | 5.31571040 |
| 4 | Stomatitis (HP:0010280) | 5.30166577 |
| 5 | T lymphocytopenia (HP:0005403) | 4.83654336 |
| 6 | Abnormality of T cell number (HP:0011839) | 4.65198910 |
| 7 | Nonimmune hydrops fetalis (HP:0001790) | 4.60898289 |
| 8 | Reduced antithrombin III activity (HP:0001976) | 4.55183053 |
| 9 | Abnormality of the pons (HP:0007361) | 4.20223082 |
| 10 | Abnormal protein N-linked glycosylation (HP:0012347) | 4.07111779 |
| 11 | Abnormal protein glycosylation (HP:0012346) | 4.07111779 |
| 12 | Abnormal glycosylation (HP:0012345) | 4.07111779 |
| 13 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 4.07111779 |
| 14 | Hypoplasia of the pons (HP:0012110) | 3.94676484 |
| 15 | Abnormality of T cells (HP:0002843) | 3.79599999 |
| 16 | Myopathic facies (HP:0002058) | 3.67662057 |
| 17 | IgM deficiency (HP:0002850) | 3.67198984 |
| 18 | Hypochromic microcytic anemia (HP:0004840) | 3.58941786 |
| 19 | Gastrointestinal infarctions (HP:0005244) | 3.42927582 |
| 20 | Abnormality of T cell physiology (HP:0011840) | 3.39384966 |
| 21 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.37560340 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.22146886 |
| 23 | Oligomenorrhea (HP:0000876) | 3.15847648 |
| 24 | Entropion (HP:0000621) | 3.13507318 |
| 25 | Duplicated collecting system (HP:0000081) | 3.09786253 |
| 26 | Severe combined immunodeficiency (HP:0004430) | 3.05780599 |
| 27 | Hypochromic anemia (HP:0001931) | 2.96807336 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 2.96067077 |
| 29 | Chronic diarrhea (HP:0002028) | 2.93264011 |
| 30 | Thin bony cortex (HP:0002753) | 2.88453963 |
| 31 | Poikiloderma (HP:0001029) | 2.87243306 |
| 32 | Abnormality of the renal collecting system (HP:0004742) | 2.86606929 |
| 33 | IgG deficiency (HP:0004315) | 2.82839779 |
| 34 | Acute hepatic failure (HP:0006554) | 2.76512417 |
| 35 | Abnormality of macrophages (HP:0004311) | 2.75916316 |
| 36 | Fatigue (HP:0012378) | 2.72503114 |
| 37 | Prolonged QT interval (HP:0001657) | 2.60561221 |
| 38 | Clubbing of toes (HP:0100760) | 2.55223026 |
| 39 | Increased IgM level (HP:0003496) | 2.51341977 |
| 40 | Generalized aminoaciduria (HP:0002909) | 2.50035868 |
| 41 | 3-Methylglutaconic aciduria (HP:0003535) | 2.43106797 |
| 42 | Decreased subcutaneous fat (HP:0001002) | 2.41056012 |
| 43 | Peritonitis (HP:0002586) | 2.40403122 |
| 44 | Hyponatremia (HP:0002902) | 2.39545902 |
| 45 | Abnormality of eosinophils (HP:0001879) | 2.37675764 |
| 46 | Enlarged epiphyses (HP:0010580) | 2.36186211 |
| 47 | Combined immunodeficiency (HP:0005387) | 2.33656536 |
| 48 | Hepatocellular necrosis (HP:0001404) | 2.30466683 |
| 49 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.29253620 |
| 50 | Toxemia of pregnancy (HP:0100603) | 2.26871661 |
| 51 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.24836707 |
| 52 | Encephalitis (HP:0002383) | 2.24145367 |
| 53 | Amelogenesis imperfecta (HP:0000705) | 2.21948792 |
| 54 | Methylmalonic acidemia (HP:0002912) | 2.21633319 |
| 55 | Recurrent viral infections (HP:0004429) | 2.20777650 |
| 56 | Recurrent fungal infections (HP:0002841) | 2.18944040 |
| 57 | Poor head control (HP:0002421) | 2.17564344 |
| 58 | Chest pain (HP:0100749) | 2.17555869 |
| 59 | Pustule (HP:0200039) | 2.16048612 |
| 60 | Thyroiditis (HP:0100646) | 2.15944913 |
| 61 | Azoospermia (HP:0000027) | 2.15406508 |
| 62 | Abnormality of the preputium (HP:0100587) | 2.15326843 |
| 63 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.12577757 |
| 64 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.12577757 |
| 65 | Eosinophilia (HP:0001880) | 2.09476080 |
| 66 | Absent thumb (HP:0009777) | 2.08853101 |
| 67 | Abnormality of the costochondral junction (HP:0000919) | 2.08289701 |
| 68 | Optic neuritis (HP:0100653) | 2.05008114 |
| 69 | Retrobulbar optic neuritis (HP:0100654) | 2.05008114 |
| 70 | Granulocytopenia (HP:0001913) | 2.04456983 |
| 71 | Keratoconjunctivitis sicca (HP:0001097) | 2.02448741 |
| 72 | Aplastic anemia (HP:0001915) | 2.02200866 |
| 73 | Eczematoid dermatitis (HP:0000976) | 2.01863482 |
| 74 | Abnormality of the ileum (HP:0001549) | 2.01034552 |
| 75 | Vasculitis (HP:0002633) | 1.99535129 |
| 76 | Meningitis (HP:0001287) | 1.97871741 |
| 77 | Leukocytosis (HP:0001974) | 1.96792425 |
| 78 | Malignant hyperthermia (HP:0002047) | 1.96071438 |
| 79 | Autoimmune thrombocytopenia (HP:0001973) | 1.95990109 |
| 80 | Meckel diverticulum (HP:0002245) | 1.95704028 |
| 81 | Keratitis (HP:0000491) | 1.95154181 |
| 82 | Milia (HP:0001056) | 1.94999280 |
| 83 | Delayed epiphyseal ossification (HP:0002663) | 1.93686598 |
| 84 | Myositis (HP:0100614) | 1.93274967 |
| 85 | Lymphopenia (HP:0001888) | 1.92565958 |
| 86 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.89482470 |
| 87 | Deep venous thrombosis (HP:0002625) | 1.88756992 |
| 88 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.88709736 |
| 89 | Polycythemia (HP:0001901) | 1.87955893 |
| 90 | Esophageal atresia (HP:0002032) | 1.87591462 |
| 91 | Arthropathy (HP:0003040) | 1.86346365 |
| 92 | Concave nail (HP:0001598) | 1.85460822 |
| 93 | Exotropia (HP:0000577) | 1.85378058 |
| 94 | Orchitis (HP:0100796) | 1.85264667 |
| 95 | Urticaria (HP:0001025) | 1.84980528 |
| 96 | Methylmalonic aciduria (HP:0012120) | 1.84901472 |
| 97 | Keratoconjunctivitis (HP:0001096) | 1.83014238 |
| 98 | Episodic fever (HP:0001954) | 1.81455920 |
| 99 | Recurrent abscess formation (HP:0002722) | 1.80961612 |
| 100 | Mediastinal lymphadenopathy (HP:0100721) | 1.80720929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 6.75856130 |
| 2 | MAP4K1 | 5.54705798 |
| 3 | KDR | 3.54218601 |
| 4 | ZAP70 | 3.50023927 |
| 5 | IKBKE | 3.43103895 |
| 6 | MAP3K13 | 3.22177828 |
| 7 | TXK | 2.92982109 |
| 8 | MAP3K11 | 2.56812964 |
| 9 | MAPK15 | 2.41824049 |
| 10 | RIPK4 | 2.36616617 |
| 11 | TESK2 | 2.25480905 |
| 12 | SCYL2 | 2.25278423 |
| 13 | CAMKK2 | 2.17780016 |
| 14 | MAP3K14 | 2.15320008 |
| 15 | FES | 2.08047763 |
| 16 | BLK | 1.99542838 |
| 17 | NEK9 | 1.96557401 |
| 18 | MAP3K12 | 1.76404448 |
| 19 | JAK3 | 1.73170583 |
| 20 | CSK | 1.69773700 |
| 21 | MARK3 | 1.68139866 |
| 22 | IKBKB | 1.65598714 |
| 23 | ITK | 1.63256398 |
| 24 | TNK2 | 1.60994992 |
| 25 | SYK | 1.47366783 |
| 26 | BTK | 1.39256967 |
| 27 | CAMKK1 | 1.28820244 |
| 28 | LCK | 1.28192587 |
| 29 | TBK1 | 1.23875890 |
| 30 | ZAK | 1.14558664 |
| 31 | WNK4 | 1.12799935 |
| 32 | PIM1 | 1.09035621 |
| 33 | CAMK1D | 1.05536025 |
| 34 | TIE1 | 1.03534865 |
| 35 | TYK2 | 1.03480126 |
| 36 | LYN | 1.00573542 |
| 37 | EPHB1 | 0.95806811 |
| 38 | TEC | 0.83953247 |
| 39 | MAP3K5 | 0.82067155 |
| 40 | NME1 | 0.81518947 |
| 41 | ADRBK2 | 0.79108350 |
| 42 | PRKCI | 0.78075654 |
| 43 | CLK1 | 0.77656028 |
| 44 | PRKCQ | 0.77439754 |
| 45 | GRK1 | 0.74402196 |
| 46 | PASK | 0.73813461 |
| 47 | CDK12 | 0.70835908 |
| 48 | PRKCH | 0.70625125 |
| 49 | GRK5 | 0.67901031 |
| 50 | CSF1R | 0.66544523 |
| 51 | BMPR2 | 0.66416543 |
| 52 | TESK1 | 0.63267054 |
| 53 | GRK6 | 0.59917526 |
| 54 | HIPK2 | 0.55066852 |
| 55 | MAPK10 | 0.51777496 |
| 56 | FGR | 0.51033688 |
| 57 | BCKDK | 0.50850000 |
| 58 | HCK | 0.50497787 |
| 59 | PDK1 | 0.49976618 |
| 60 | OXSR1 | 0.49759830 |
| 61 | STK38 | 0.48751384 |
| 62 | KSR1 | 0.44940043 |
| 63 | PKN2 | 0.40635175 |
| 64 | JAK1 | 0.39876709 |
| 65 | MAP3K1 | 0.38270067 |
| 66 | TRIB3 | 0.38118421 |
| 67 | STK10 | 0.37369709 |
| 68 | PTK2B | 0.37262841 |
| 69 | CAMK1G | 0.36588331 |
| 70 | STK11 | 0.35958696 |
| 71 | FRK | 0.34479999 |
| 72 | RPS6KA5 | 0.33439749 |
| 73 | EIF2AK3 | 0.32954964 |
| 74 | LRRK2 | 0.32421246 |
| 75 | MAP2K3 | 0.31875794 |
| 76 | SMG1 | 0.30730536 |
| 77 | MAP2K2 | 0.30438119 |
| 78 | WNK1 | 0.30254671 |
| 79 | CSNK1A1 | 0.29416360 |
| 80 | RIPK1 | 0.29212036 |
| 81 | TYRO3 | 0.29098508 |
| 82 | RPS6KA6 | 0.28278874 |
| 83 | TAOK2 | 0.28270714 |
| 84 | PTK6 | 0.27978709 |
| 85 | IRAK4 | 0.27146320 |
| 86 | YES1 | 0.26678829 |
| 87 | RPS6KC1 | 0.25890461 |
| 88 | RPS6KL1 | 0.25890461 |
| 89 | NEK1 | 0.25579322 |
| 90 | CHUK | 0.23361654 |
| 91 | PRPF4B | 0.22791502 |
| 92 | CAMK4 | 0.22453006 |
| 93 | CDK4 | 0.21896185 |
| 94 | MAPK3 | 0.21838122 |
| 95 | MAP3K7 | 0.21630655 |
| 96 | JAK2 | 0.21528916 |
| 97 | UHMK1 | 0.20447050 |
| 98 | TSSK6 | 0.19642047 |
| 99 | NLK | 0.19522908 |
| 100 | INSR | 0.18881357 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.48731611 |
| 2 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.47494636 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 3.02618462 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.98752315 |
| 5 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.62801572 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.62576696 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.54094654 |
| 8 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.52534220 |
| 9 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.45564601 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.39521322 |
| 11 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 2.38881557 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.24833162 |
| 13 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.09223727 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.98323842 |
| 15 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.81026348 |
| 16 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.80827266 |
| 17 | Phototransduction_Homo sapiens_hsa04744 | 1.79739074 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.71319274 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68989314 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.67603189 |
| 21 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.64021366 |
| 22 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.63489790 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.63457881 |
| 24 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.53725942 |
| 25 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48601097 |
| 26 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47723533 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.40719593 |
| 28 | Viral myocarditis_Homo sapiens_hsa05416 | 1.38513404 |
| 29 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.35314477 |
| 30 | Proteasome_Homo sapiens_hsa03050 | 1.26521908 |
| 31 | Mineral absorption_Homo sapiens_hsa04978 | 1.22677051 |
| 32 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.20965174 |
| 33 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.20286433 |
| 34 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.15272491 |
| 35 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.14801670 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.14616351 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12984471 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08436730 |
| 39 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.08169934 |
| 40 | Asthma_Homo sapiens_hsa05310 | 1.06696559 |
| 41 | ABC transporters_Homo sapiens_hsa02010 | 1.06493034 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 1.06218211 |
| 43 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.05156510 |
| 44 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.99786604 |
| 45 | Influenza A_Homo sapiens_hsa05164 | 0.89449419 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 0.87205141 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85353085 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.84687728 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.84278282 |
| 50 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83283167 |
| 51 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.83211055 |
| 52 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81071021 |
| 53 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.76029240 |
| 54 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.74815162 |
| 55 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.72784745 |
| 56 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.72727908 |
| 57 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.70473408 |
| 58 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69330923 |
| 59 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68941926 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.67712522 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.64928301 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.61946091 |
| 63 | Tuberculosis_Homo sapiens_hsa05152 | 0.60943676 |
| 64 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.58112022 |
| 65 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55288834 |
| 66 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.52390377 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.49284027 |
| 68 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.49259578 |
| 69 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.45586084 |
| 70 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.43441572 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.42662139 |
| 72 | Bile secretion_Homo sapiens_hsa04976 | 0.41301270 |
| 73 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39869816 |
| 74 | Hepatitis C_Homo sapiens_hsa05160 | 0.39817140 |
| 75 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.35994290 |
| 76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.35668882 |
| 77 | Parkinsons disease_Homo sapiens_hsa05012 | 0.34570717 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.34229508 |
| 79 | Renin secretion_Homo sapiens_hsa04924 | 0.33457579 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31809158 |
| 81 | Shigellosis_Homo sapiens_hsa05131 | 0.31766130 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.30593750 |
| 83 | RNA degradation_Homo sapiens_hsa03018 | 0.29544674 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29173416 |
| 85 | RNA transport_Homo sapiens_hsa03013 | 0.28806877 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.27954375 |
| 87 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.27903141 |
| 88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.25203585 |
| 89 | Olfactory transduction_Homo sapiens_hsa04740 | 0.23998802 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.21692349 |
| 91 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.20736761 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.20537665 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | 0.19618932 |
| 94 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.19017416 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.16437465 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.16171623 |
| 97 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.15486748 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.15347330 |
| 99 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.15101114 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.14823919 |

